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Abstract The biological role of Ap3A synthesized in cells by 
tryptophanyl-tRNA synthetase (WRS) is unknown. Previously 
we have demonstrated that the cellular level of Ap3A signifi-
cantly increases after interferon treatment. Here we show that 
the human 46 kDa 2-5A synthetase efficiently utilizes Ap3A as a 
primer for oligoadenylate synthesis. The Km for Ap3A is several-
fold lower than for Ap4A and 100-fold lower than for ATP. This 
implies that Ap3A might be a natural primer for the 2'-
adenylation reaction catalysed by 2-5A synthetase. Since WRS 
and 2-5A synthetase are both interferon-inducible proteins, a new 
link between two interferon-dependent enzymes is established. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
It is well known that aminoacyl- tRNA synthetases (aaRS) 
catalyze the formation of aminoacyladenylates (for review see 
[1]). In the presence of cognate t R N A the activated amino 
acyl residue is transferred to the 3 ' terminal ribose of t R N A 
or in excess of A T P the enzyme-bound aminoacyl adenylate is 
converted to A p 4 A (AppppA, diadenosine 5',5'"-P1,P4-tetra-
phosphate). The A p 4 A synthesis is catalyzed by a series of 
bacterial and mammalian aaRS (for review see [2]). Contrary 
to the majority of aaRS, t ryptophanyl- tRNA synthetase 
(WRS) fails to promote A p 4 A synthesis [3]. Instead, it cata-
lyses the diadenosine 5',5'"-P1 ,P3-triphosphate (Ap3A, App-
pA) synthesis in the presence of A D P [4]. The cellular func-
tion of the A p 3 A remains obscure. Specific Ap 3 A/Ap 4 A 
asymmetrical hydrolase, called F H I T , was recently identified, 
sequenced and characterized in human cells [5,6]. 
Another peculiar property of the human W R S that clearly 
distinguishes this aaRS from all other aaRS is its interferon 
(IFN) inducibility [7-9] due to the presence of IFN-responsive 
regulatory elements GAS and ISRE in the promoter region of 
its gene [10-12]. The relation between the cell response to-
wards I F N and the increased levels of W R S activity remains 
obscure. Several hypotheses have been proposed to accommo-
date this unusual behavior of WRS, a housekeeping enzyme, 
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and the IFN action [7,8,13-16]. One of them suggests that as a 
consequence of the W R S induction, IFNs may promote accu-
mulation of A p 3 A that may serve as an intermediate in the 
I F N signal transduction [17]. In fact, the A p 3 A accumulation 
was demonstrated experimentally in cell cultures of monocytic 
and lymphocytic origin [18]. In an at tempt to find the poten-
tial target(s) of A p 3 A action we assumed that A p 3 A may serve 
as a substrate for another IFN-inducible enzyme, 2-5A syn-
thetase [19-21]. This enzyme produces 2-5A from A T P by 
non-processive mechanism [21,22]. It has been proposed that 
2-5A synthetase exhibits two binding sites, one for the primer 
(the acceptor) of the 2'-adenylation reaction, and one for ATP 
(donor) [22]. Besides 2-5A and ATP, 2-5A synthetase can 
adenylate several other nucleotides and oligonucleotides 
[23,24], and all ribonucleoside triphosphates can serve as do-
nors. The only prerequisite for being an acceptor is the avail-
ability of the ribose 2 ' -OH group as in ATP, N A D H , t R N A , 
ApA, CpA, etc. Since the symmetric diadenosineoligophos-
phates meet this requirement, we assume that A p 3 A and 
A p 4 A could serve as substrates for 2-5A synthetase. The 
aim of this work was to prove experimentally this assumption. 
2. Materials and methods 
2.1. Purification of enzyme from Hi Five cells 
Hi Five cells infected for 72 h with a recombinant AcMNPV (Pia 
Miller Martensen, personal communication) containing a cDNA for 
2-5A synthetase (46 kDa form) were lysed on ice for 10 min in 20 mM 
Tris-HCl, pH 7.5; 0.5 M K(CH3COO); 5 mM Mg(CH3COO)2 ; 1 mM 
EDTA; 1% Nonidet-40; 2% glycerol. The cell extract was cleared by 
centrifugation. Ammonium sulfate was added to the cleared cell ex-
tract to a final concentration of 1.1 M, incubated for 30 min on ice, 
and then centrifuged for 10 min at 20000Xg. 
Ammonium sulfate was added to the supernatant to a final concen-
tration of 1.7 M, loaded on a phenyl-Sepharose 6FF column (Phar-
macia). The column was washed with a decreasing ammonium sulfate 
gradient (1.7-0 M). The proteins were eluted by ethylene glycol (gra-
dient 0-50%). Peak fractions were identified by enzyme activity meas-
urements using the spectrophotometric 2-5A synthetase assay as de-
scribed [25]. The active fractions were subsequently loaded onto a 
MonoS column (Pharmacia, HR5/5) in 50 mM HEPES, pH 7.8; 50 
mM K(CH3COO); 5 mM Mg(KCH3COO)2; 5% glycerol and eluted 
with increasing salt concentrations (linear gradient of K(CH3COO), 
50 mM-1 M). Fractions with 2-5A synthetase activity were pooled 
and used for further analysis. Protein concentration was measured as 
described [26]. 
2.2. Ap?,A adenylation by dATP 
Incubation mixture (final volume 50 ul) contained 20 mM Tris-HCl, 
pH 7.8; 10 mM MgCl2; 0.2 mM DTT; 0.1 mM EDTA; 0.1 mg/ml 
BSA; 5% glycerol; 0.1 uCi of [a-32P]dATP (Amersham); 0.5 mg/ml 
poly(I)-poly(C); 0.05 ug of 2-5A synthetase; dATP and Ap3A (or 
Ap4A) as indicated. The activity of 2-5A synthetase was determined 
by taking 10 ui aliquots after 10, 20, 30, 40 and 60 min of incubation 
at 25°C. After heat denaturation (90°C, 5 min) aliquots were treated 
with alkaline phosphatase (final concentration 0.3 U/ml) at 37°C for 
3 h, and spotted onto PEI-cellulose plates. PEI chromatography was 
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Fig. 1. Identification by PEI chromatography of Ap3A and Ap4A adenylation products. X-ray autoradiograms after exposition for 48 h. Filled 
arrows indicate mobility of the markers. A : Adenylation of Ap3 A by ATP. Incubation medium (50 ul) contained 20 u,M Ap3 A, 0.2 |o,Ci of [a-
32P]ATP, 400 uM ATP. Incubation for 1 h at 25°C. B: Time course for adenylation of Ap3A by dATP. Incubation mixture contained 34 u,M 
AP3A, 12 iiM dATP. Incubation time: lane 1, 10 min; lane 2, 20 min; lane 3, 30 min; lane 4, 40 min; lane 5, 60 min. C: Time course for ad-
enylation of Ap4A by dATP. Incubation mix contained 60 uM Ap4A, 12 uM dATP. Incubation time: lane 1, 10 min; lane 2, 20 min; lane 3, 
30 min; lane 4, 40 min; lane 5, 60 min. 
performed as described [20] using 2 M Tris-HCl, pH 8.83. ATP, ADP, 
Ap3A, Ap4A (Sigma) were used as reference standards. 32P incorpo-
ration was measured by Phosphorimager (Molecular Dynamics) and 
respective bands quantitated by ImageQuant software. Autoradio-
grams were prepared by exposure of PEI-cellulose plates to X-ray 
films at —70°C with intensifying screen. 
2.3. Ap?,A adenylation by ATP 
Incubation mixture (final volume 100 ul) contained 20 mM Tris-
HCl, pH 7.8; 10 mM MgCl2; 0.2 mM DTT; 0.1 mM EDTA; 0.1 mg/ 
ml BSA; 5% glycerol; 0.5 mg/ml poly(I)-poly(C) ; 6 mM creatine 
phosphate; 0.1 mg/ml creatine phosphokinase; 0.1 ug of 2-5A synthe-
tase; Ap3A [ot-32P]ATP and ATP as indicated. After incubation for 4 h 
at 37°C, reaction was stopped by heat denaturation and incubation 
mixture was treated with alkaline phosphatase before separation by 
TLC or FPLC. 
2.4. FPLC analysis of oligonucleotides 
The heat-inactivated reaction mixture (Section 2.3) was treated by 
alkaline phosphatase (Boehringer-Mannheim), diluted 10-fold in buff-
er A (20 mM Tris-HCl, pH 7.5) and applied to a MonoQ column 
(Pharmacia, HR5/5). The nucleotides were eluted by a linear salt 
gradient in buffer A (0-0.7 M NaCl) and detected at 254 nm. The 
flow rate was 0.5 ml/min, the volume of gradient was 25 ml. Analyt-
ical runs with and without alkaline phosphatase treatment and with a 
number of standard compounds (Ap3A, Ap4A, and ATP) were per-
formed to establish the identity of the different compounds synthe-
sized. 
3. Results 
That Ap3A reacts with ATP in the presence of 2-5A syn-
thetase and its activator poly(I)-poly(C) forming ApppA2'p5-
'A was first shown by TLC of radioactivity labelled nucleo-
tides (Fig. 1A). The ApppA2'p5'A product remains a good 
substrate for 2-5A synthetase capable of reacting with another 
ATP molecule. The TLC shows that the initial product could 
be elongated with up to four additional AMP residues. How-
ever, with the resolution achieved by FPLC (MonoQ) of un-
labelled molecules (Fig. 2A,B), up to 6 AMP residues per one 
Ap3A primer could be visualized. The yield of the longer 
products is lower than for the shorter products. Since the 
Ap3A molecule possesses two free 2'-OH groups, the di-
and triadenylated Ap3A are represented by two isomers, tet-
raadenylated Ap3A is a mixture of 3 isomers, etc. The isomers 
can be identified by MonoQ column chromatography (Fig. 
2B), where tri- and tetraadenylated Ap3A each are visible as 
peaks with several summits. 
To evaluate the substrate properties of diadenosineoligo-
phosphates for 2-5A synthetase, kinetic analysis of the App-
pA2'p5'dA synthesis was undertaken. In these experiments, 
dATP was used instead of ATP as donor in order to prevent 
2-5A chain elongation. The adenylation yield depends linearly 
on dATP concentration in the range from 12 to 250 u\M (data 
not shown). Reduction of the monoadenylated Ap3A amount 
by its utilization for dA5'p2'ApppA2'p5'dA synthesis from 
ApppA2'p5'dA and dATP was only 2% (Fig. IB) and this 
diminution was not taken into account in the calculations. 
Fig. 3A shows the results of kinetic measurements in dou-
K. Turpaev et al.lFEBS Letters 408 (1997) 177-181 179 
0.2 -i 
Ë a 
*t 
m 
CM 
£ 
O 
■t-> 
Q. 
i ~ 
O 
CO 
< 
0 J 
r-0.35 
c 
CD 
05 
ö 
CD 
r 
o 10 Time (min) 50 
B 
r0.35 
c 
0) 
T5 
CD 
- a> 
ö 
CD 
0.05 
0 10 Time (min) 50 
Fig. 2. Chromatography on MonoQ column of 2-5A synthetase 
products. Reaction conditions as described in Section 2.3. A: Sepa-
ration of 2-5-oligoadenylates. Incubation mixture contained 1 mM 
ATP. B: Separation of AP3A adenylation products. Incubation mix-
ture contained 1 mM ATP and 0.5 mM Ap3A. 
Fig. 3. The effect of Ap3A/Ap4A concentrations on 2-5A synthetase 
activity. Reactions were performed in the presence of dATP as de-
scribed in Section 2.2. Double-reciprocal plots represent the varia-
tion in rate of Ap3A/Ap4A adenylation with initial concentrations 
of these substrates. Enzyme activity is expressed in nmol of adeny-
lated Ap3A/Ap4A per min, per mg of protein. A: Inverse data plot 
for reaction of Ap3A2'p5'dA synthesis. The values of fixed dATP 
concentrations for each line are indicated on the figure. B: Inverse 
data plot for reaction of Ap4A2'p5'A synthesis. The fixed concen-
tration of dATP was 12 uM. 
ble-reciprocal plots for the reaction rate and the Ap3A con-
centration as the variable. Three fixed dATP concentrations 
were applied, 12, 60, and 200 u.M. At these concentrations, 
Km for ApßA was found to be 14.7, 18.0 and 71 uM, respec-
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Fig. 4. Schematic representation of the Ap3A metabolism and regu-
lation pathways. Open arrows indicate proposed reactions. RNase L 
is activated by nanomolar levels of 2-5A resulting in breakdown of 
RNA in cells. We suggest that 2'-adenylated Ap3A serves as modu-
lator of RNase L. We also suggest the possibility that Ap3A hydro-
lase FHIT cleaves Ap3A(2'p5'A)n resulting in production of 
ppA(2'p5'A)n and following activation of RNase L. 
tively. It is seen that two of these three curves are parallel to 
each other at low dATP concentrations. This implies that the 
2'-adenylation reaction follows a ping-pong mechanism. Pre-
sumably, pyrophosphate split from dATP leaves the enzyme 
before the binding of Ap3A to the 2-5A synthetase. We also 
performed the same measurements for AP4A as a substrate at 
12 uM ATP (Fig. 1C). Under these conditions, Km for Ap4A 
was found to be 99 (iM (Fig. 3B). Therefore, Km for Ap3A is 
7 fold lower than for Ap4A under the same reaction condi-
tions. 
4. Discussion 
Ap3A and Ap4A are products of a side reaction catalyzed 
by several aaRS, and so far these are the only enzymes that 
produce these diadenosinepolyphosphates. Ap3A and Ap4A 
have been proposed to be intracellular signalling molecules 
which regulate DNA synthesis and stress responses [2]. Ex-
tracellular signalling function (binding to receptors of purines) 
of these nucleotides in blood and in neural secretory tissues 
has been suggested [27,28], and of intracellular functions there 
exist hypotheses for growth stimulatory effects due to affinity 
for DNA polymerases [2,29]. In this work we have demon-
strated that Ap3A and Ap4A serve as very good substrates for 
pure human 2-5A synthetase (46 kDa form). Both diadenosi-
neoligophosphates are much better substrates for 2-5A syn-
thetase than, for example, ATP (Km 2 mM) [30,31]. Moreover, 
Ap3A has several-fold better affinity towards the enzyme than 
Ap4A. Thus, the Km for Ap3A is comparable with the basal 
concentration of this dinucleotide in mammalian cells [32]. 
This may indicate that Ap3A is a specific natural substrate 
for 2-5A synthetase. Indirectly, this conclusion is strengthened 
by the fact that Ap3A efficiently competes with ATP for 2-5-
oligoadenylate formation (Fig. 1A,B). Moreover, 2-5A syn-
thetase apart from 2'-adenylation of Ap3A is capable of fur-
ther elongating the Ap3A up to at least six adenylate residues. 
Therefore, Ap3A serves as a specific primer (acceptor) for 2-
5A synthesis. We have thus established a link between WRS 
and 2-5A synthetase, two enzymes of the IFN system. 
What is the cellular role of Ap3A(pA)n synthesized by 2-5A 
synthetase? This new compound may bind to IFN-inducible 
RNase L known to be activated by 2-5(A)n (when n > 2 ) 
[33,34] and serve as either its competitive inhibitor or an alter-
native activator. We can suggest that Ap3A(pA)n serves as a 
potential substrate to the Ap3A hydrolase FHIT. This human 
enzyme cleaves Ap3A to AMP and ADP [5]. If the same 
reaction also proceeds with 2'-adenylated Ap3A, then the 
products would be AMP and a 2',5'-oligoadenylate, bearing 
a 5'-pyrophosphate group, ppA(pA)n. When n is greater than 
1, this compound can even in nanomolar concentrations acti-
vate RNase L [33,35]. Thus, IFN treatment causes accumu-
lation in cells of a primer for 2-5A synthetase activity that 
subsequently could accelerate the cellular response to dsRNA-
containing virus invasion. If 2-5A products are secreted, it 
may be important that the Ap3A(pA)n is resistant to phos-
phatase activity, whereas the classical 2-5-oligoadenylates are 
very sensitive. This could point to a function of Ap3A(pA)n as 
a extracellular signalling molecule in blood and other tissues. 
All reactions revealed in this work and predicted from our 
observations are schematically depicted in Fig. 4. 
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